0000014272-15-000048.txt : 20150210
0000014272-15-000048.hdr.sgml : 20150210
20150210181102
ACCESSION NUMBER: 0000014272-15-000048
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150206
FILED AS OF DATE: 20150210
DATE AS OF CHANGE: 20150210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moed Samuel J
CENTRAL INDEX KEY: 0001561017
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 15595424
MAIL ADDRESS:
STREET 1: BRISTOL-MYERS SQUIBB COMPANY
STREET 2: ROUTE 206 & PROVINCELINE ROAD
CITY: LAWRENCEVILLE
STATE: NJ
ZIP: 08543
4
1
wf-form4_142360985199080.xml
FORM 4
X0306
4
2015-02-06
0
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001561017
Moed Samuel J
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
0
1
0
0
SVP, Strat Plan & Analysis
Common Stock, $0.10 par value
2015-02-06
4
M
0
27938
22.14
A
59838.464
D
Common Stock, $0.10 par value
2015-02-06
4
S
0
21478
60.154
D
38360.464
D
Option (right to buy)
22.14
2015-02-06
4
M
0
27938
0
D
2018-03-03
Common Stock, $0.10 par value
27938.0
0
D
A portion of these shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $60.08 to $60.185, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
All of the shares are currently exercisable.
/s/ Robert J. Wollin, attorney-in-fact for Samuel J. Moed
2015-02-10